亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Targeted Delivery to the Heart Endothelium

技術優勢
No other methods exist currently to deliver drugs or genes specifically to the heart endothelium
技術應用
Targeted drug delivery vehicles Contrast agents for imaging
詳細技術說明
Ligand-targeted liposomes are increasingly being recognized as an effective strategy to deliver drugs to specific organs; however, few studies have quantified endothelial binding of targeted liposomes. Researchers at the University of California, Davis have discovered that embedding high concentrations of short, linear, arginine-terminated peptides into nanoparticles allows for concentrated binding of the particles selectively to heart endothelium and the vascular endothelium in the heart.
*Abstract

Targeted delivery of nanoparticles to the heart endothelium with large pay-load potential, applicable to drug/gene delivery.

*IP Issue Date
Aug 13, 2013
*Principal Investigation

Name: Katherine Ferrara

Department:


Name: Jiro Kusnose

Department:


Name: Hua Zhang

Department:

附加資料
Patent Number: US8506928B2
Application Number: US2008206569A
Inventor: Ferrara, Katherine | Zhang, Hua | Kusunose, Jiro
Priority Date: 7 Sep 2007
Priority Number: US8506928B2
Application Date: 8 Sep 2008
Publication Date: 13 Aug 2013
IPC Current: A61K005100 | A61M003614
US Class: 42400169 | 42400111 | 42400165 | 42400181 | 42400185 | 42400189
Assignee Applicant: The Regents of the University of California
Title: Methods and compounds for targeting tissues
Usefulness: Methods and compounds for targeting tissues
Summary: The composition is useful for delivering therapeutic agent e.g. amnioterone or digoxin, or imaging agent e.g. radiolabel, such as [ 18 F], [ 18 F]FDP or 64Cu, preferably [ 18 F]FDP or dye to a cell e.g. mammalian cell, human cell, cardiac cell, endothelial cell, cardiac endothelial cell, human coronary artery endothelial cell (HCAEC), human umbilical vein endothelial cells (HUVEC), brain cell or cancer cell, preferably cardiac endothelial cell for positron emission tomography (PET) imaging by administering the composition (all claimed), and for treating and/or diagnosing diseases such as cardiovascular diseases.
Novelty: Composition for delivering compound e.g. therapeutic agent or imaging agent to cell e.g. human cell for diagnosing or treating diseases e.g. cardiovascular disease, comprises peptide, particle for carrying compound, and linking molecule
主要類別
診斷/治療
細分類別
癌症/腫瘤
申請號碼
8506928
其他

Related Materials

Zhang H, Kusunose J, Kheirolomoom A, Seo JW, Qi J, Watson KD, Lindfors HA, Ruoslahti E, Sutcliffe JL, and Ferrara KW. 2008. Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model. Biomaterials. 29(12):1976-88. Epub 2008 Feb 6.


Additional Technologies by these Inventors


Tech ID/UC Case

11237/2008-157-0


Related Cases

2008-157-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備